Verweij Marieke C, Wellish Mary, Whitmer Travis, Malouli Daniel, Lapel Martin, Jonjić Stipan, Haas Juergen G, DeFilippis Victor R, Mahalingam Ravi, Früh Klaus
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
PLoS Pathog. 2015 May 14;11(5):e1004901. doi: 10.1371/journal.ppat.1004901. eCollection 2015 May.
Varicella zoster virus (VZV) causes chickenpox in humans and, subsequently, establishes latency in the sensory ganglia from where it reactivates to cause herpes zoster. Infection of rhesus macaques with simian varicella virus (SVV) recapitulates VZV pathogenesis in humans thus representing a suitable animal model for VZV infection. While the type I interferon (IFN) response has been shown to affect VZV replication, the virus employs counter mechanisms to prevent the induction of anti-viral IFN stimulated genes (ISG). Here, we demonstrate that SVV inhibits type I IFN-activated signal transduction via the JAK-STAT pathway. SVV-infected rhesus fibroblasts were refractory to IFN stimulation displaying reduced protein levels of IRF9 and lacking STAT2 phosphorylation. Since previous work implicated involvement of the VZV immediate early gene product ORF63 in preventing ISG-induction we studied the role of SVV ORF63 in generating resistance to IFN treatment. Interestingly, SVV ORF63 did not affect STAT2 phosphorylation but caused IRF9 degradation in a proteasome-dependent manner, suggesting that SVV employs multiple mechanisms to counteract the effect of IFN. Control of SVV ORF63 protein levels via fusion to a dihydrofolate reductase (DHFR)-degradation domain additionally confirmed its requirement for viral replication. Our results also show a prominent reduction of IRF9 and inhibition of STAT2 phosphorylation in VZV-infected cells. In addition, cells expressing VZV ORF63 blocked IFN-stimulation and displayed reduced levels of the IRF9 protein. Taken together, our data suggest that varicella ORF63 prevents ISG-induction both directly via IRF9 degradation and indirectly via transcriptional control of viral proteins that interfere with STAT2 phosphorylation. SVV and VZV thus encode multiple viral gene products that tightly control IFN-induced anti-viral responses.
水痘带状疱疹病毒(VZV)可引发人类水痘,随后在感觉神经节中潜伏,从该部位重新激活后会导致带状疱疹。恒河猴感染猴水痘病毒(SVV)可重现人类VZV发病机制,因此是VZV感染的合适动物模型。虽然已表明I型干扰素(IFN)反应会影响VZV复制,但该病毒会采用对抗机制来阻止抗病毒IFN刺激基因(ISG)的诱导。在此,我们证明SVV通过JAK-STAT途径抑制I型IFN激活的信号转导。感染SVV的恒河猴成纤维细胞对IFN刺激具有抗性,表现为IRF9蛋白水平降低且缺乏STAT2磷酸化。由于先前的研究表明VZV立即早期基因产物ORF63参与阻止ISG诱导,我们研究了SVV ORF63在产生对IFN治疗抗性中的作用。有趣的是,SVV ORF63不影响STAT2磷酸化,但以蛋白酶体依赖性方式导致IRF9降解,这表明SVV采用多种机制来对抗IFN的作用。通过与二氢叶酸还原酶(DHFR)降解结构域融合来控制SVV ORF63蛋白水平进一步证实了其对病毒复制的必要性。我们的结果还显示,VZV感染的细胞中IRF9显著减少且STAT2磷酸化受到抑制。此外,表达VZV ORF63的细胞阻断了IFN刺激并显示IRF9蛋白水平降低。综上所述,我们的数据表明水痘ORF63通过直接降解IRF9以及间接通过干扰STAT2磷酸化的病毒蛋白的转录控制来阻止ISG诱导。因此,SVV和VZV编码多种病毒基因产物,可严格控制IFN诱导的抗病毒反应。